Recruiting studies: Prostate Cancer After A Radical Treatment

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

177Lu-PSMA as a Systemic Adjuvant Treatment in Patients With High and Very High Risk Prostate Cancer
Phase 2 · 1 location(s) · Maria Sklodowska-Curie National Research Institute of Oncolo · NCT06449781 This Study is Evaluating a New Radiation Treatment Technique for Patients Who Have Had Prostate Cancer, Undergone Surger
Phase 2 · 1 location(s) · University of Rochester · NCT05946824 Diagnostic Performance of [18F]PSMA-1007 in the Context of Biochemical Recurrence of Prostate Cancer
Phase N/A · 1 location(s) · Heinrich-Heine University, Duesseldorf · NCT06657131 Salvage Radiotherapy Combined With Androgen Deprivation Therapy (ADT) With or Without Rezvilutamide in the Treatment of
Phase 2 · 2 location(s) · The Affiliated Nanjing Drum Tower Hospital of Nanjing Univer · NCT06305832 Long-term Better Than Short-term ADT With Salvage RT
Phase 2/Phase 3 · 3 location(s) · Universitaire Ziekenhuizen KU Leuven · NCT04242017 FK-PC101 as Adjuvant Therapy for Men With High-Risk Prostate Cancer
Phase 2 · 3 location(s) · Cellvax Therapeutics Inc · NCT06636682 Adjuvant Rezvilutamide Monotherapy for High-Risk Prostate Cancer After Radical Prostatectomy
Phase 2 · 1 location(s) · The Affiliated Nanjing Drum Tower Hospital of Nanjing Univer · NCT07711314

Look up another condition

Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.